Is There a Vaccine for Tuberculosis TB Health ConditionsFeaturedBreast CancerIBD MigraineMultiple Sclerosis (MS)Rheumatoid ArthritisType 2 DiabetesSponsored TopicsArticlesAcid RefluxADHDAllergiesAlzheimer's & DementiaBipolar DisorderCancerCrohn's DiseaseChronic PainCold & FluCOPDDepressionFibromyalgiaHeart DiseaseHigh CholesterolHIVHypertensionIPFOsteoarthritisPsoriasisSkin Disorders and CareSTDsDiscoverWellness TopicsNutritionFitnessSkin CareSexual HealthWomen's HealthMental HealthSleepOriginal SeriesFresh Food FastDiagnosis DiariesYou’re Not AlonePresent TenseVideo SeriesYouth in FocusHealthy HarvestNo More SilenceFuture of HealthPlanHealth ChallengesMindful EatingSugar SavvyMove Your BodyGut HealthMood FoodsAlign Your SpineFind CarePrimary CareMental HealthOB-GYNDermatologistsNeurologistsCardiologistsOrthopedistsLifestyle QuizzesWeight ManagementAm I Depressed? A Quiz for TeensAre You a Workaholic?How Well Do You Sleep?Tools & ResourcesHealth NewsFind a DietFind Healthy SnacksDrugs A-ZHealth A-ZConnectFind Your Bezzy CommunityBreast CancerInflammatory Bowel DiseasePsoriatic ArthritisMigraineMultiple SclerosisPsoriasisFollow us on social mediaShopProducts by ConditionInsomniaStress ReliefBack PainNeck PainSleep ApneaHot SleepersAllergiesPain ReliefProduct ReviewsVitamins & SupplementsSleepMental HealthNutritionAt-Home TestingCBDMen’s HealthWomen’s HealthHealth ConditionsDiscoverPlanConnectShopSubscribe

Is There a Vaccine for Tuberculosis TB

Medically reviewed by Karen Gill, M.D. — By Jill Seladi-Schulman, Ph.D. on October 10, 2022There’s a vaccine available for tuberculosis. However, it’s not commonly given in the United States. One reason why is that tuberculosis is no longer as common in the United States as it once was. Tuberculosis (TB) is an infection caused by the bacteria Mycobacterium tuberculosis. It most often affects the lungs. It’s contagious, meaning that it can be transmitted from person to person. This article will go into more detail about the TB vaccine, who needs it, and what to know about its safety and effectiveness.

Who needs a TB vaccine

The TB vaccine is called Bacillus Calmette-Guérin (BCG). It’s made from a weakened form of the bacterium Mycobacterium bovis, which causes a TB-like illness in cattle. Exposure to BCG can help your body generate an immune response against M. tuberculosis, which causes TB in humans. According to the Centers for Disease Control and Prevention (CDC), BCG isn’t typically recommended in the United States. This is due to:the low risk of contracting TB in the United Statesvariations in the effectiveness of BCG to prevent TB in adultsthe possibility of BCG interfering with tuberculin skin tests, which are used to detect TB infections After a consultation with a doctor experienced in TB, BCG may be recommended for:children who do not have TB but are often exposed to TB, or cannot be separated from an adult who:hasn’t been treated for TB, orhas drug-resistant TBhealthcare professionals who are working in areas where there’s a high percentage of people with TB or ongoing TB transmission, especially of drug-resistant strains In countries where TB is more common, BCG is still widely used. According to the World Health Organization (WHO), BCG is given to more than 80% of all newborns and infants in countries where it’s a part of a national immunization program.

How effective is the TB vaccine

In countries where TB is common, BCG is mainly used to protect against two types of severe TB in infants and young children: TB meningitis and disseminated TB. Against these types of TB, BCG provides up to 80% protection. However, this protection doesn’t last forever. A 2022 study found that BCG vaccination at birth only provided significant protection against any type of TB to children under 5 years old. It was not effective for older children and adults. A 2016 study looked into the effectiveness of BCG in protecting against pulmonary (lung) TB. Researchers found that vaccine effectiveness against this specific type of TB became statistically insignificant 20 years after vaccination. As you may have noticed, the vaccine effectiveness estimates for BCG in adults are highly variable. According to one 2021 review of research, studies have found that the effectiveness of BCG in adults has ranged from zero to 80%. While more research is needed to help explain this large variation, scientists have some ideas about why this happens, such as:exposure to other Mycobacterium species in the environment masking or blocking an immune response to BCGimmune system or genetic variations between peopledifferences between the strains of BCG used to make the vaccine

Is the TB vaccine safe

Like many vaccines, BCG can cause side effects. The most common are skin changes at the vaccination site. Many people who receive the BCG vaccine develop a pustule or blister at the vaccination site. This typically appears 10 to 14 days after vaccination. It can be present for 4 to 6 weeks before it goes away. Other potential side effects of the BCG vaccine include:feverheadacheswollen lymph nodes There are also some more serious, although rare, side effects of the BCG vaccine, including:ulcer or abscess formation at the vaccination sitea severe allergic reaction (anaphylaxis)bone inflammation or infection

Is there anyone who shouldn t receive BCG

Some people should not receive BCG, such as:People with a weakened immune system: BCG is a live vaccine and can cause potentially serious problems for people with a weakened immune system. You may have a weakened immune system if you:are taking immunosuppressant medicationsare being treated for cancerhave had an organ or bone marrow transplantare living with HIVhave an inherited immunodeficiency syndromePregnant people: According to the BCG package insert, although no harmful effects to a developing fetus have been seen, reproduction studies haven’t been done. As such, BCG isn’t currently recommended for pregnant people.Allergies: If you have a known allergy to any component of the BCG vaccine, it’s not recommended that you get it.

How common is TB

The rate of TB in the United States is low. According to the CDC, a total of 7,174 cases of TB were reported in 2020. While TB isn’t a large public health threat in the United States, that’s not the case for many other parts of the world. According to the WHO, a total of 10 million people across the globe fell ill with TB in 2020. There were also 1.5 million deaths from TB worldwide in 2020. The WHO also notes that 30 countries with high TB levels account for most new TB cases. Countries that are especially impacted include:IndiaChinaIndonesiathe PhilippinesPakistanNigeriaBangladeshSouth Africa

Are newer TB vaccines being developed

Researchers are working to develop a newer, more effective TB vaccine. However, the lack of understanding about why exactly BCG is so variable in effectiveness makes designing a new vaccine quite challenging. A 2022 review notes that at least 14 new vaccines for TB are in clinical development. These use different types of vaccine technology, including:live, which uses a weakened form of a germsubunit, which uses only a piece of a germviral vector, which uses a modified virus to deliver the vaccine contents The success of the mRNA vaccines for COVID-19 has also sparked interest in using the same technology to develop a TB vaccine. In fact, a 2022 paper has already proposed a potential mRNA construct to begin testing in laboratory studies.

The bottom line

BCG is currently the only vaccine for TB. Because TB isn’t common in the United States, it’s not typically recommended for use in the country. However, it’s still a widely used vaccine in many other parts of the world. BCG is mainly given to infants and young children to help protect them from very severe forms of TB. When used in this context, it’s very effective. However, BCG isn’t very protective in older children, adolescents, and adults. This variation in effectiveness is driving a search for a newer, more effective TB vaccine. Researchers are exploring many technologies to achieve this, including mRNA vaccine technology. Last medically reviewed on October 10, 2022

How we vetted this article

SourcesHistoryHealthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.BCG vaccine fact sheet. (2016).
cdc.gov/tb/publications/factsheets/prevention/bcg.htmBCG vaccine for tuberculosis (TB) FAQs. (2019).
nhs.uk/conditions/vaccinations/bcg-tb-vaccine-questions-answers/BCG vaccine U.S.P. (for percutaneous use). (n.d.).
fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---BCG-Vaccine.pdfBCG vaccine. (n.d.).
who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/bcgDavenne T, et al. (2016). Why don't we have an effective tuberculosis vaccine yet?
ncbi.nlm.nih.gov/pmc/articles/PMC4950406/de Gijsel D, et al. (2019). A breath of fresh air: BCG prevents adult pulmonary tuberculosis.
sciencedirect.com/science/article/pii/S1201971219301006Dockrell HM, et al. (2022). Tuberculosis vaccines in the era of COVID-19 – what is taking us so long?
thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00177-3/fulltextKumar P. (2021). A perspective on the success and failure of BCG.
frontiersin.org/articles/10.3389/fimmu.2021.778028/fullMartinez L, et al. (2022). Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: A systematic review and individual participant data meta-analysis.
thelancet.com/journals/langlo/article/PIIS2214-109X(22)00283-2/fulltextMoliva JI, et al. (2017). Immune responses to Bacillus Calmette–Guérin vaccination: Why do they fail to protect against Mycobacterium tuberculosis?
ncbi.nlm.nih.gov/pmc/articles/PMC5380737/Nguipdop-Djomo P, et al. (2016). Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: A retrospective population-based cohort study.
thelancet.com/journals/laninf/article/PIIS1473-3099(15)00400-4/fulltextOkafor CN, et al. (2022). Bacillus Calmette Guerin.
ncbi.nlm.nih.gov/books/NBK538185/TB incidence in the United States, 1953-2020. (2021).
cdc.gov/tb/statistics/tbcases.htmTbeishat HA. (2022). Novel in silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications.
nature.com/articles/s41598-022-08506-4Tuberculosis. (2021).
who.int/news-room/fact-sheets/detail/tuberculosisVaccines. (2022).
cdc.gov/tb/topic/basics/vaccines.htmOur experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Current Version Oct 10, 2022 By Jill Seladi-Schulman, PhD Edited By Rosalie Rung Medically Reviewed By Karen Richardson Gill, MD Copy Edited By Sara Giusti Share this articleMedically reviewed by Karen Gill, M.D. — By Jill Seladi-Schulman, Ph.D. on October 10, 2022

Read this next

Vaccine Schedule for Infants and ToddlersMedically reviewed by Karen Gill, M.D. Vaccines help protect children against many dangerous diseases. Find out what vaccines are recommended and when they should be given.READ MOREHow to Treat Drug-Resistant Tuberculosis Drug-resistant tuberculosis is an increasingly common disease, describing 1 in 5 cases of TB. We review the causes, types, and treatment options.READ MORETypes of TuberculosisMedically reviewed by Jill Seladi-Schulman, Ph.D. There are many types of tuberculosis, categorized by the areas of the body that are affected. Learn about some of the most common types as well as…READ MOREHow to Identify a Positive Tuberculosis (TB) Skin TestMedically reviewed by Danielle Hildreth, RN, CPT A positive tuberculosis (TB) skin test can look different depending on your risk factors. Learn risk factors to consider and what a positive test may…READ MOREBCG Tuberculosis Vaccine: New Findings Could Help Develop Future Vaccines The vaccine for tuberculosis was originally developed in 1921, and it is still in use today. Researchers recently compared the effects of tuberculosis…READ MORETuberculosisMedically reviewed by Alana Biggers, M.D., MPH Tuberculosis (TB), a highly infectious disease, primarily affects the lungs. Learn more about risk factors, symptoms, prevention, and treatment. READ MOREIs Tuberculosis Contagious and How Is It Spread?Medically reviewed by Daniel Murrell, M.D. Tuberculosis is a highly contagious infection. Seek immediate help if you think you've been exposed. A doctor can do a simple test to determine if you…READ MORE*clone Market VIP* The 11 Best Mattresses for Lower Back Pain in 2022Medically reviewed by Gregory Minnis, DPT These 11 picks are some of the best mattresses for lower back pain. Offering medium-firm support, they’ll help keep you aligned and rested.READ MOREWhat Is Post-Intensive Care Syndrome?Medically reviewed by Debra Rose Wilson, Ph.D., MSN, R.N., IBCLC, AHN-BC, CHT Post-intensive care syndrome is a group of physical, cognitive, and mental health issues that can occur after severe illness, most often after a stay…READ MORE